(Q66084104)

English

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Multiple Dose Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity (English)

0 references

0 references

0 references

United States of America

0 references

start time

18 August 2016

0 references

end time

3 September 2017

0 references

number of participants

187

0 references

research intervention

liraglutide

0 references

clinical trial phase

phase I clinical trial

0 references

minimum age

18 year

0 references

maximum age

55 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02870231

0 references

(Q66084104)

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)